We only have this paper's title and publication details.
Read it at the sourceObservational analysis reveals that ctDNA tumor fraction predicts clinical benefit in a pan-cancer population, suggesting potential use in treatment monitoring.
Timing of sample collection
No takes yet. Share an insight, caveat, or question.
Liang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: